EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blocking MyD88 Signaling Pathway Protects Against Myocardial Ischemia Reperfusion by Inhibiting NOX/ROS Pathway and Enhancing eNOS Activity

Bo Wang, Xia Huang, Lin Xie iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Bo Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China. Hauptthemen laut MEDLINE: Myeloid Differentiation Factor 88, Nitric Oxide Synthase Type III, Reactive Oxygen Species, Myocardial Reperfusion Injury. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tongji Hospital Scientific Research Fund Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial ischemia–reperfusion injury (MIRI) remains a major complication in acute coronary syndrome and cardiac surgery, with oxidative stress and metabolic dysregulation serving as central pathogenic drivers. This study aimed to clarify whether the novel MyD88 inhibitor TJ-M2010-5 confers cardioprotection against MIRI by remodeling immune–metabolic homeostasis, particularly through regulating NADPH oxidase (NOX)-derived reactive oxygen species (ROS) overproduction and endothelial nitric oxide synthase (eNOS) functional activity. In this study, male C57BL/6 mice were subjected to 30 min myocardial ischemia followed by 24 h reperfusion, with or without TJ-M2010-5 pretreatment (50 mg/kg, i.p.), and mouse cardiac vascular endothelial cells (H5V) were exposed to hypoxia–reoxygenation (H/R) with or without TJ-M2010-5 intervention. We systematically evaluated myocardial infarct size, ROS production, cell apoptosis, NF-κB activation, NOX expression and activity, NADPH redox homeostasis, NO production, and eNOS phosphorylation levels. The results showed that TJ-M2010-5 significantly reduced myocardial infarct size and inhibited IKKβ/NF-κB activation in I/R-treated mice, and functionally disrupted MyD88 homodimerization in ischemic myocardium. In H/R-challenged H5V cells, TJ-M2010-5 decreased ROS generation and cell apoptosis, suppressed NOX2/NOX4 expression and activity, restored NADPH levels and NADP+/NADPH redox balance, preserved tissue NO content, and maintained eNOS Ser1177 phosphorylation. In conclusion, pharmacologic blockade of MyD88 by TJ-M2010-5 alleviates NOX-dependent oxidative stress, stabilizes NADPH redox homeostasis, preserves NO bioavailability, and maintains eNOS functional activity, thereby exerting potent cardioprotective effects against MIRI via regulating redox homeostasis. The TLR/MyD88–NOX/ROS–eNOS signaling axis represents a novel and promising redox-regulatory therapeutic target for the clinical prevention and treatment of MIRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloid Differentiation Factor 88Nitric Oxide Synthase Type IIIReactive Oxygen SpeciesMyocardial Reperfusion InjurySignal TransductionNADPH OxidasesAnimalsMiceMaleMice, Inbred C57BLNF-kappa BOxidative StressApoptosisEndothelial Cells

Stichwörter der Autor:innen

Innate immunityMyD88 signalingNADPHNOXROSRedox homeostasiseNOSischemia–reperfusion injurymyocardial

Substanzen

Myeloid Differentiation Factor 88Nitric Oxide Synthase Type IIIReactive Oxygen SpeciesNADPH OxidasesNF-kappa BMyd88 protein, mouse

Autor:innen und Institutionen

  • Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430074, China.
  • Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology; Key Laboratory of Organ Transplantation, Ministry of Education; NHC Key Laboratory of Organ Tra…

ORCID-Profile: Lin Xie

Förderung

  • National Natural Science Foundation of China
  • Tongji Hospital Scientific Research Fund Project

Zitieren

APA

Wang, B., Huang, X., & Xie, L. (2026). Blocking MyD88 Signaling Pathway Protects Against Myocardial Ischemia Reperfusion by Inhibiting NOX/ROS Pathway and Enhancing eNOS Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188299

Vancouver

Wang B, Huang X, Xie L. Blocking MyD88 Signaling Pathway Protects Against Myocardial Ischemia Reperfusion by Inhibiting NOX/ROS Pathway and Enhancing eNOS Activity. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188299

BibTeX
@article{Wang2026,
  author = {Wang, Bo and Huang, Xia and Xie, Lin},
  title = {Blocking MyD88 Signaling Pathway Protects Against Myocardial Ischemia Reperfusion by Inhibiting NOX/ROS Pathway and Enhancing eNOS Activity},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188299}
}
Kostenlos starten →